Publication

Badger TA, Segrin C, Crane TE, Chalasani P, Arslan W, Hadeed M, Sikorskii A. 2022. Social Determinants of Health and Symptom Burden During Cancer Treatment. Nursing Research. 72(2):103–113. doi:10.1097/nnr.0000000000000636.

Thrul J, Howe CL, Devkota J, Alexander A, Allen AM, Businelle MS, Hébert ET, Heffner JL, Kendzor DE, Ra CK, et al. 2022. A Scoping Review and Meta-analysis of the Use of Remote Biochemical Verification Methods of Smoking Status in Tobacco Research. Nicotine and Tobacco Research. 25(8):1413–1423. doi:10.1093/ntr/ntac271.

Alrawashdh N, McBride A, Erstad B, Sweasy J, Persky DO, Abraham I. 2022. Cost-Effectiveness and Economic Burden Analyses on All First-Line Treatments of Chronic Lymphocytic Leukemia. Value Health. 25:1685–1695. doi:10.1016/j.jval.2022.04.001.

Chakrabarti J, Pandey R, Churko JM, Eschbacher J, Mallick S, Chen Y, Hermes B, Mallick P, Stansfield BN, Pond KW, et al. 2022. Development of Human Pituitary Neuroendocrine Tumor Organoids to Facilitate Effective Targeted Treatments of Cushing’s Disease. Cells. 11(21):3344.

Atwell B, Chen C-Y, Christofferson M, Montfort WR, Schroeder J. 2022. Sorting nexin-dependent therapeutic targeting of oncogenic epidermal growth factor receptor. Cancer Gene Therapy. 30(2):267–276. doi:10.1038/s41417-022-00541-7.

Wallace RL, Lu E, Luo X, Capaldi AP. 2022. Ait1 regulates TORC1 signaling and localization in budding yeast. eLife. 11. doi:10.7554/elife.68773.

You S, Kim M, Hoi XP, Lee YC, Wang L, Spetzler D, Abraham J, Magee D, Jain P, Galsky MD, et al. 2022. Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti–PD-L1 Immune Checkpoint Therapy. JNCI: Journal of the National Cancer Institute. 114(10):1380–1391.

Watanabe M, Jergović M, Davidson L, LaFleur BJ, Castaneda Y, Martinez C, Smithey MJ, Stowe RP, Haddad EK, Nikolich‐Žugich J. 2022. Inflammatory and immune markers in HIV‐infected older adults on long‐term antiretroviral therapy: Persistent elevation of sCD14 and of proinflammatory effector memory T cells. Aging Cell. 21(9). doi:10.1111/acel.13681.

de Renty C, Pond KW, Yagle MK, Ellis NA. 2022. BLM Sumoylation Is Required for Replication Stability and Normal Fork Velocity During DNA Replication. Frontiers in Molecular Biosciences. 9. doi:10.3389/fmolb.2022.875102.

Krunz M, Zhang W, Ditzler G. 2022. Application of adversarial machine learning in protocol and modulation misclassification. In: Pham T, Solomon L, Hohil ME, editors. Artificial Intelligence and Machine Learning for Multi-Domain Operations Applications IV. SPIE. p. 57.

Ryniawec JM, Coope MR, Loertscher E, Bageerathan V, de Oliveira Pessoa D, Warfel NA, Cress AE, Padi M, Rogers GC. 2022. GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors. Diagnostics. 12(3):676. doi:10.3390/diagnostics12030676.

Fox RS, Fowler B, Carrera JB, Reichek J, Sanford SD. 2022 Mar. Increasing access to psychosocial care for adolescents and young adults with cancer by integrating targeted navigation services. Psychooncology. doi:10.1002/pon.5916.

Harryman WL, Marr KD, Nagle RB, Cress AE. 2022. Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers. Frontiers in Cell and Developmental Biology. 10. doi:10.3389/fcell.2022.837585.

Goodrich JM, Jung AM, Furlong MA, Beitel S, Littau S, Gulotta J, Wallentine D, Burgess JL. 2022. Repeat measures of DNA methylation in an inception cohort of firefighters. Occupational and Environmental Medicine. 79(10):656–663. doi:10.1136/oemed-2021-108153.

Kwak E-A, Pan CC, Ramonett A, Kumar S, Cruz-Flores P, Ahmed T, Ortiz HR, Lochhead JJ, Ellis NA, Mouneimne G, et al. 2022. βIV-spectrin as a stalk cell-intrinsic regulator of VEGF signaling. Nature Communications. 13(1). doi:10.1038/s41467-022-28933-1.

Dennis LK. 2022. Cumulative Sun Exposure and Melanoma in a Population-Based Case–Control Study: Does Sun Sensitivity Matter?. Cancers. 14(4):1008. doi:10.3390/cancers14041008.

Skiba MB, Lopez-Pentecost M, Werts SJ, Ingram M, Vogel RM, Enriquez T, Garcia L, Thomson CA. 2022. Health Promotion Among Mexican-Origin Survivors of Breast Cancer and Caregivers Living in the United States-Mexico Border Region: Qualitative Analysis From the Vida Plena Study. JMIR Cancer. 8:e33083. doi:10.2196/33083.

Powell DA, Hsu AP, Shubitz LF, Butkiewicz CD, Moale H, Trinh HT, Doetschman T, Georgieva TG, Reinartz DM, Wilson JE, et al. 2022. Mouse Model of a Human STAT4 Point Mutation That Predisposes to Disseminated Coccidiomycosis. ImmunoHorizons. 6(2):130–143. doi:10.4049/immunohorizons.2200007.

Adegboyega A, Aleshire M, Wiggins AT, Palmer K, Hatcher J. 2022. A Motivational Interviewing Intervention to Promote CRC Screening: A Pilot Study. Cancer Nurs. 45:E229-E237. doi:10.1097/NCC.0000000000000905.

Yellowhair M, Jones D, Ruiz G, Castanos O, Herrera R, Contreras J, Garcia D, Hatcher J. 2022. Abstract 434: Development of virtual outreach strategies to supply cancer education and prevention information during the COVID-19 pandemic. doi:10.1158/1538-7445.AM2022-434.

Jones D, Ruiz G, Contreras J, Herrera R, Lee A, Yellowhair M, Hatcher J. 2022. Abstract 5938: Administering colorectal cancer education via an inflatable colon with the underrepresented and underserved population of Arizona. doi:10.1158/1538-7445.AM2022-5938.

Langston M, Brown H, Lynch C, Roe D, Dennis L. 2022. Ambient UVR is a risk factor for cutaneous melanoma, but not environmental arsenic exposure. Int J Environ. Res. Public Health. 2022; 19, 1742. https://doi.org/10.3390/ijerph1903174.

Amiri S, Greer MD, Muller CJ, Johansson P, Petras A, Allick CC, London SM, Abbey MC, Halasz LM, Buchwald D. Disparities in Access to Radiation Therapy by Race and Ethnicity in the United States With Focus on American Indian/Alaska Native People. Value Hea. 2022.

Bonaventura J, Morara K, Carlson R, Comrie C, Daigle N, Hutchinson E, Sawyer T. 2022. Backscattering Mueller Matrix polarimetry on whole brain specimens shows promise for minimally invasive mapping of microstructural orientation features. Front. Photon. 3, (2022).

Wusterbarth E, Chen Y, Jecius H, Krall E, Runyan RB, Pandey R, Nfonsam V. 2022. Cartilage Oligomeric Matrix Protein, COMP may be a Better Prognostic Marker Than CEACAM5 and Correlates With Colon Cancer Molecular Subtypes, Tumor Aggressiveness and Overall Survival. J Surg Res. 270:169–177. doi:10.1016/j.jss.2021.09.007.